Nalagenetics aims to reduce adverse drug reactions and increase prescription efficacy by offering genetic testing and robust information management systems to doctors and patients.
Location: Singapore
Employees: 11-50
Total raised: $12.6M
Founded date: 2016
Investors 2
| Date | Name | Website |
| - | Integra Pa... | integrapar... |
| - | Brama One ... | brama-one.... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 25.03.2022 | Series A | $12.6M | - |
Mentions in press and media 12
| Date | Title | Description |
| 29.10.2025 | Basepair and NalaGenetics Form Strategic Collaboration to Launch Next Generation Clinical Genomics Platform | Basecamp combines best-in-class bioinformatics with clinical genomics, accelerating precision healthcare. We see Basecamp as a breakthrough platform for hospitals and laboratories seeking to integrate pharmacogenomics, germline testing and ... |
| 21.04.2022 | MGI announces partnership with Nalagenetics to advance pharmacogenomics in Singapore and Indonesia | The partnership will address some critical issues in pharmacogenetic assay through sequencing workflows improvement SINGAPORE – Media OutReach – 21 April 2022 – MGI, a company committed to being a world-leading life science innovator, today... |
| 19.04.2022 | MGI announces partnership with Nalagenetics to advance personalized medicine | The partnership will address some critical issues in pharmacogenetic assay through sequencing workflows improvement SINGAPORE, April 19, 2022 /PRNewswire/ -- MGI, a company committed to being a world-leading life science innovator, today an... |
| 26.03.2022 | Nalagenetics raised $12.6 M in Series A round to expand its genome analysis platform | Nalagenetics, a Southeast Asian firm that provides genetic testing services, announced today the completion of a $12.6 million Series A fundraising round. Strategic investors included Singapore-based Diagnostics Development Hub (DxD Hub) th... |
| 25.03.2022 | Nalagenetics Raises US$12.6M in Series A Funding | Nalagenetics, a Singapore-based provider of genetic testing solutions in Southeast Asia, closed a US$12.6m Series A financing. The round was co-led by Intudo Ventures and Vulcan Capital, with participation from strategic investors, includin... |
| 22.03.2022 | Intudo, Vulcan Capital lead $12.6m funding for SG gene testing firm | InvestmentsNewsStartups Aditya Hadi Pratama · 25 Mar 2022 · 2 min readIntudo, Vulcan Capital lead $12.6m funding for SG gene testing firm Nalagenetics, a Singapore-based genetic testing company, has raised US$12.6 million in a series A roun... |
| 30.04.2021 | Early-bird price ends tonight: Buy your pass to TC Early Stage 2021 and save $100 | Last call, founders. Today is your last chance to save $100 on a pass to TC Early Stage 2021: Marketing & Fundraising. Our last founder bootcamp event of the year takes place July 8-9, and it’s time to call on Saint Expeditus — the patr... |
| 26.04.2021 | Save $100 on TC Early Stage 2021: Marketing and Fundraising before this Friday | Save $100 and learn how to build a stronger startup — that’s what we’re talking about! The crème de la crème of the startup ecosystem will gather on July 8-9 to share their expertise and impart their hard-won wisdom at TC Early Stage 2021: ... |
| 19.04.2021 | Less than 2 weeks left to save $100 on TC Early Stage 2021: Marketing and Fundraising | Regret — such an unfortunate and unnecessary emotion, is it not? If you missed out on our April TC Early Stage bootcamp, this is your chance to cast regret aside and secure your spot at TC Early Stage 2021: Marketing and Fundraising on July... |
| 02.04.2021 | Don’t miss the Pitch-Off today at TC Early Stage 2021 | Ten global startups, three rounds of pitching, nine expert judges. It’s not the 12 Days of Startups (no robotic partridge in a pear tree here), it’s the TC Early Stage Pitch-Off — otherwise known as day two of TC Early Stage 2021: Operation... |
Show more